| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


*Department of Chemical and Biomolecular Engineering,
Department of Bioengineering, and Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Correspondence: Address reprint requests to Daniel A. Hammer, Dept. of Bioengineering, University of Pennsylvania, 120 Hayden Hall, 3320 Smith Walk, Philadelphia, PA 19104. Tel.: 215-573-6761; Fax: 215-573-2071; E-mail: hammer{at}seas.upenn.edu.
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Regardless of the mechanism of integrin activation, what is clear is that rolling is essential for firm arrest and eventual transmigration of leukocytes to inflamed tissues. The question is, is there any role for selectin-mediated rolling in facilitating the transition to firm adhesion beyond the activation of integrins? More generally, the paradigm of two molecules, each with different physical chemistry and capable of supporting different dynamics states of adhesion, acting in concert, is ubiquitous in adhesion biology, but the precise interplay between two different molecule systems is not understood. Therefore, the goal of this article is to systematically construct an experimental system that will allow us to understand the fundamental biophysical interplay between two molecules, motivated by leukocyte adhesion biology, and thus suggest a mechanism by which selectins may facilitate the transition to firm adhesion via integrins.
To do this, we will use cell-free systems in which microspheres coated with two ligands, sialyl LewisX (sLex) and an antibody against ICAM-1 (BBIG-I1), are allowed to interact with selectin/ICAM-1 surfaces under flow, mimicking the weak ligand-strong ligand chemistry present in leukocyte adhesion. Specifically, sLeX/P-selectin interactions have been shown to support rolling adhesion (Rodgers et al., 2000
), and here we show that binding between anti-ICAM-I (aICAM-1) and ICAM-1 mediates firm binding. Cell-free systems such as this have successfully been used to elucidate the physical chemistry of selectin-mediated rolling (Brunk and Hammer, 1997
; Greenberg et al., 2000
; Rodgers et al., 2000
), but cell-free systems have not been used to understand the transition from rolling to firm adhesion. Fig. 1 shows a schematic illustration of the cell-free system used in this work. This system is ideal to understand the role of wall shear stress, the ratio of P-selectin/ICAM-1 surface density ratio, and the ratio of sLeX/aICAM-1 density in the transition from rolling to firm adhesion in a two-receptor system because in a cell-free system we can adjust the properties of the system systematically in ways that are not easily achieved in cell systems. Our results show that at several intermediate sLeX/aICAM-1 ratios, selectin-ligand interactions are critical for optimal ICAM-1-mediated firm adhesion. We find that the amount of firmly adhering microspheres is dependent on wall shear stress, P-selectin/ICAM-1 surface density ratio, and sLeX/aICAM-1 microsphere site density ratio. We show that removing sialyic acid from sLeX, which renders the carbohydrate inactive as a rolling ligand, greatly reduces the extent of firm adhesion. In addition, we show that ICAM-1 interactions stabilize rolling, by decreasing the average rolling velocity and increasing the pause times during microsphere rolling. The suggestion that the results of our model system are indicative of mechanisms that may be at play in leukocyte adhesion is enhanced by our finding that the on-rate for aICAM-1 binding to ICAM-1 is within a factor of 1.5 of that between activated ß2-integrin and ICAM-1. Overall, we believe this article identifies a mechanistic role of selectins in facilitating the transition to firm adhesion in leukocytes.
|
| MATERIALS AND METHODS |
|---|
|
|
|---|
Substrate preparation
P-selectin/ICAM-1 surfaces were prepared by a method similar to that described in previous publication (Rodgers et al., 2000
). In this method, double well, rectangular, flexiperm gaskets (Sigma, St. Louis, MO) were placed on microscope slides cut from bacteriological polystyrene dishes. The surface enclosed by one of the two wells was incubated overnight with 374 µL of 2.5, 5, or 10 µg/mL ICAM-1 in binding buffer (0.1 M NaHCO3) and the other well with binding buffer. After ICAM-1 incubation, ICAM-1 coated surfaces were washed twice with 2 mL binding buffer, after which the double well gaskets were replaced with single well, rectangular gaskets. The surfaces enclosed by the single well gaskets were coated with 800 µL of 12, 10, or 4 µg/mL P-selectin in binding buffer for a period of 2 h. After coating with P-selectin, the surfaces were incubated with 2 mL of a heat-denatured solution of 2% bovine serum albumin (BSA) in Dulbecco's phosphate buffered saline (DPBS) (pH = 7.4) for a minimum of 30 min, and before use in laminar flow assays, slides were incubated for 2 min with 1% Tween 20 in DPBS. Control surfaces were prepared using the BSA blocking step only.
P-selectin/ICAM-1 site density determination
For site density determination, eight-well, rectangular, flexiperm gaskets were placed on polystyrene slides. ICAM-1 was incubated overnight at one concentration, followed by P-selectin incubation for 2 h as described in the previous section. After protein incubation, wells were coated with 2% denatured BSA solution. BSA-blocked, P-selectin/ICAM-1 surfaces were then incubated with a saturating concentration of FITC-labeled aICAM-1 mAb (BBIG-I1) or anti-P-selectin mAb (9E1). Fluorescence intensity was obtained using FeliX software (Photon Technologies, Severna Park, MD) and a Nikon Diaphot inverted microscope (Melville, NY) equipped with a FITC cube and connected to a photomultiplier tube (Photoscan, Nikon, Tokyo, Japan). P-selectin/ICAM-1 site density (molecules/µm2) was obtained using calibration curves generated by measuring the fluorescence of known concentrations of anti-P-selectin and aICAM-1 mAbs as previously described (Brunk and Hammer, 1997
).
Microsphere preparation
Biotinylated sLeX, a 30-kD carbohydrate probe that has been described in previous publications (Brunk and Hammer, 1997
; Greenberg et al., 2000
; Rodgers et al., 2000
), and biotinylated aICAM-1 mAb were diluted to 5 µg/mL in DPBS+, (DPBS, 1% BSA, pH = 7.4). These two solutions were then mixed at ratios between 0% and 100% sLeX. A total of 106 SuperAvidin-coated beads (
10 µm) were simultaneously coated with sLeX and anti-ICAM-1 by incubating the beads with 100 µL solution containing different ratios of biotinylated sLeX and aICAM-1 mAb for 1 h at room temperature, with continuous vortexing. Beads were then washed three times in DPBS+ and resuspended in 2 mL DPBS+ until ready for use in adhesion experiments.
Carbohydrate and antibody site density determination
For sLeX site density determination, 105 aICAM-1/sLeX-coated beads were incubated with 100 µL of 30 µg/ml rat-IgM anti-human Cutaneous Lymphocyte Antigen (CLA) reactive to sLeX (HECA-452) for 1 h. Beads were then washed two times with DPBS+ and incubated for 1 h with 100 µL of 30 µg/ml FITC-labeled anti-rat IgM mAb. Fluorescence intensities were measured using flow cytometry, and sLeX site densities were estimated as described previously (Brunk and Hammer, 1997
). Fluorescence shifts were converted to site densities using a calibration curve relating mean peak fluorescence of Quantum 26 calibration beads (Bangs Laboratories, Fishers, IN) to their molecules of equivalent soluble fluorochrome (MESF). Using the molecules of equivalent soluble fluorochrome/protein ratio of the FITC-conjugated secondary antibody and assuming a 1:1 relationship between sLeX, the primary and secondary antibody, the number of surface-bound molecules was determined. For anti-ICAM-1 density determination, 105 aICAM-1/sLeX-coated beads were incubated with 100 µL of 30 µg/ml FITC-conjugated anti-mouse IgG1 monoclonal antibody reactive to the mouse IgG1 residue on the biotinylated aICAM-1 mAb. Assuming a 1:1 binding ratio between aICAM-1 and the fluorescence antibody, aICAM-1 site density was calculated similar to that of sLeX.
Determination of binding constant of anti-ICAM-1 mAb (BBIG-I1) to ICAM-1
Binding kinetics of anti-ICAM-1 mAb was measured on a BIAcore 1000 instrument (BIAcore, Piscataway, NJ). StreptAvidin (SA)-chips were purchased from BIAcore and stored at 4°C before use. To begin measurement, a SA-chip was loaded into the BIAcore 1000, after which the surface was exposed to three 1-min injections of conditioning buffer (10 mM NaCl in 50 mM NaOH) at 30 µl/min. After conditioning, the chip was washed with HBS-EP buffer (10 mM HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% Tween 20) for 5 min at 20 µl/min to block nonspecific adhesion. Biotinylated anti-ICAM-1, BBIG-I1, was immobilized onto the surface by flowing 16 µg/ml antibody in HBS-EP buffer over the chip at 5 µl/min until saturation (
1700 response units). After the adsorption of aICAM-1, the surface was washed with HBS-EP for
15 min at 20 µl/min to remove excess antibody. Binding constants for the interactions between aICAM-1 and ICAM-1 were obtained by injecting various concentrations of ICAM-1 in HBS-EP buffer over the anti-ICAM-1 surface at 20 µl/min for 3 min, after which HBS-EP buffer is allowed to flow over the surface for 3 min to access the rate of ICAM-1 detachment from the surface. Fig. 2 shows how the response units (RU) vary as a function of time for the association and dissociation of ICAM-1 to antibody-immobilized surface. ka and kd, the on-rate and off-rate of aICAM-1 binding to ICAM-1, were determined by fitting a kinetic expression given by Eq. 1 to this binding data using the BIAevaluation software (BIAcore) as previously described by Labadia and co-workers (Labadia et al., 1998
).
![]() | (1) |
|
w) was calculated according to
![]() | (2) |
Data analysis
Rolling and bound flux of interacting beads were obtained manually by counting the number of rolling and bound beads in the window of view (0.32 mm2) over a period of 1 min. Instantaneous and average rolling velocities were obtained through digital image analysis of video recordings of adhesion experiments, using LabView software (National Instrument, Austin, TX). Instantaneous rolling velocity data were obtained every 1/10 of a second, and the average rolling velocities were obtained by taking the mean velocity of at least 10 particles continuously rolling for 3 s or longer (Rodgers et al., 2000
). The average fraction of time paused by beads was obtained by taking the mean fraction of pause time of at least five particles over a period of at least 10 s. Error bars were plotted using SE calculation unless otherwise noted. Differences in the level of firm adhesion between microspheres with different ratios of sLeX/aICAM-1 were examined using the two-tailed Student's t-test. A value of p < 0.05 was considered statistically significant.
| RESULTS |
|---|
|
|
|---|
300 sites/µm2, on resting neutrophils (Thiel et al., 1997
|
|
Binding kinetics of aICAM-1 binding to ICAM-1
The binding kinetics of anti-ICAM-1 mAb, BBIG-I1, to ICAM-1 was measured on BIACORE 1000. Fig. 4 shows the data (symbols) and global analysis fitted (line) curves of the association and dissociation interactions between antibody and ICAM-1. The on-rate (kon) and off-rate (koff) for the antibody/ICAM-1 interactions obtained using the BIAevaluation software as described in the Materials and Methods section, were 156,000 (±46,000) M-1s-1 and 1.13 (±0.11) x 10-4 s-1 respectively (where the numbers in parentheses represent SE for n = 5).
|
|
|
3-fold increase in the amount of aICAM-1 on microsphere surface as the aICAM-1 to sLeX ratio increases from 25% to 50% (see Table 1 and right ordinate on Fig. 6 B). Furthermore, at most shear rates studied, there seems to be no statistical difference in the firm adhesion (p-values were between 0.25 and 0.27) on P-selectin/ICAM-1 surfaces as the ratio of aICAM-1 to sLeX on microsphere increases from 50% to 100% aICAM-1, although there is a significant increase in the amount of aICAM-1 on microsphere surface (from 500 to 2282 sites/µm2; see Table 1 and right abscissa in Fig. 6 B). In other words, similar levels of firm adhesion are observed with microspheres with significantly different amounts of aICAM-1 present on their surface. This strongly suggests that at 50% and 75% aICAM-1 to sLeX microsphere site density ratios, the presence of rolling interactions enhances the firm adhesion of microspheres, since the same level of firm adhesion is seen with fewer aICAM-1 molecules. Perfusion of sLeX/aICAM-1 beads over P-selectin surfaces shows an insignificant level of firm adhesion at all microsphere site density ratios, which suggests there is no interaction between aICAM-1 mAb and P-selectin, and that P-selectin interactions do not support firm binding (Fig. 6 A). Correspondingly, one can examine the rolling flux under the same conditions. Fig. 6 C compares the rolling and binding flux of sLeX/aICAM-1 beads on a 50:50 P-selectin/ICAM-1 surface. This plot shows that rolling flux progressively decreases as the ratio of sLeX to aICAM-1 decreases. Clearly, the absence of sLeX (for beads with 100% aICAM-1) prevents rolling, i.e., anti-ICAM-1 does not support rolling interactions by itself as suggested by its high affinity binding to ICAM-1. Furthermore, the large drop (80% decrease) in the rolling flux of beads over P-selectin/ICAM-1 surfaces seen as aICAM-1 ratio increases from 25% to 50% reflects the transition from rolling to firm adhesion of sLeX/aICAM-1 coated microspheres, since such a sharp decrease is not observed with beads interacting with P-selectin only (17% decrease) (Fig. 6 A). Fig. 6 C also illustrates that the total accumulation of beads on a surface is constant or decreases slightly for all aICAM-1 sLeX combinations, except for beads without any sLeX (100% aICAM-1). This data suggest some minimal presence of sLeX is necessary for maximal accumulation, but that aICAM-1 is capable of some extent of accumulation in the absence of sLeX.
We also examined the influence of the P-selectin/ICAM-1 surface ratio on the extent of firm adhesion. Microspheres with different ratios of sLeX/aICAM-1 were perfused over surfaces with 30:70, 50:50, 80:20, and 100:0 P-selectin/ICAM-1 site density ratios. Fig. 7 A illustrates how the firm binding of microspheres changes on these P-selectin/ICAM-1 surfaces. When the beads with lower sLeX/aICAM-1 ratios (aICAM-1 >50%) interact with P-selectin/ICAM-1 surfaces, firm adhesion increased as the amount of ICAM-1 on the surface increased. However, binding of beads with aICAM-1 ratio <50% (higher sLeX/aICAM-1 ratios) was limited; increasing ICAM-1 concentration did not always lead to an increase in adhesion, suggesting that the extent of adhesion is not solely due to ICAM-1 interactions. Fig. 7 B compares the rolling and binding flux of 50% sLeX/aICAM-1 coated beads on surfaces with different ratios of P-selectin/ICAM-1. As the molecular surface density ratio increases from 0% to 50% ICAM-1, we see a correlation between the decrease in rolling flux and the increase in firm binding flux, suggesting beads that had been rolling on P-selectin were now firmly bound via ICAM-1. Also, the maximum in firm binding occurs not at the highest ICAM-1 surface density, but rather when there is a 70:30 ratio of ICAM-1 to P-selectin on the surface. Therefore, firm adhesion is most likely when there is a rolling ligand in combination with a firm adhesion ligand.
|
|
|
204 ± 17.8 sites/µm2 P-selectin). As shown in these traces, sLeX/aICAM-1 beads interacting with P-selectin/ICAM-1 surfaces displayed slower rolling velocity when compared to beads rolling on pure P-selectin surface, though the selectin site density was lower on the P-selectin/ICAM-1 surface. Furthermore, these 50% aICAM-1 beads displayed long duration of pauses (periods of zero instantaneous velocity) when interacting with P-selectin/ICAM-1 surface, suggesting a gradual transition from rolling to firm adhesion. These periods of pausing are due to ICAM-1/aICAM-1 interactions, since similar beads showed short pauses or no pauses when rolling on surfaces without ICAM-1, as shown in Fig. 10 A. Fig. 10 C, showing a plot of average fraction of time paused by sLeX/aICAM-1 beads as a function of aICAM-1 bead coating ratio, shows that the fraction of time during which beads are paused increases as the ratio of aICAM-1 to sLeX increases from 0% to 100%; where at a 100% aICAM-1 ratio, no beads are rolling. This plot illustrates that the periods of pausing displayed by sLeX/aICAM-1 beads on P-selectin/ICAM-1 surfaces are indeed mediated by ICAM-1 interacting with the antibody present on microsphere surface.
|
| DISCUSSION |
|---|
|
|
|---|
Using our cell-free assay, we show that microspheres coated with sLeX and aICAM-1 will roll and bind firmly to P-selectin/ICAM-1 surfaces under flow. We show that microsphere rolling and firm adhesion is dependent on the wall shear stress within the flow chamber. As wall shear stress increases, the number of microspheres able to bind firmly with P-selectin/ICAM-1 surfaces diminishes, resulting in a decrease in the number of firmly adherent beads. Most interestingly, we find that firm adhesion of sLeX/aICAM-1 beads on P-selectin/ICAM-1 surfaces is dependent on sLeX/aICAM-1 bead site density ratio as well as the substrate surface density ratio of P-selectin/ICAM-1.
There are several distinct lines of evidence that suggest selectin-mediated rolling can facilitate the transition to firm adhesion presented in this article. They are:
Furthermore, the results of this article suggest there are regimes in which each of the molecules can control binding. In the P-selectin controlled regime, there is little firm adhesion; increasing P-selectin density or P-selectin-ligand interactions decreases the rolling velocity. In the ICAM-1 controlled regime, antibody/ICAM-1 interactions dominates, more firm adhesion is seen, and increasing P-selectin densities have little effect on the extent of firm adhesion and can actually increase rolling velocity. In between these regimes, P-selectin density plays a critical role in switching adhesion from a rolling phenotype to a firm adhesion phenotype, and greatly facilities the transition to firm adhesion. We also showed that under the right conditions, combinations of the two molecules can maintain stable rolling at a constant velocity across a wide range of concentrations.
The results of this article correspond well to the theoretical results calculated and published recently by our laboratory (Bhatia et al., 2003
). In that article, we used Adhesive Dynamics to calculate the dynamics of adhesion of leukocytes to surfaces mediated by two adhesion moleculesa selectin and an integrin. The validity of this model was verified several ways; the most compelling was a systematic comparison to experimental data on rolling in E-selectin or ß2-integrin knockout mice, in which the progressive change in rolling velocity could be accurately recreated (Fig. 11 in Bhatia et al., 2003
). This article anticipated many of the principal effects elucidate here experimentally. For instance, the state diagram for adhesion indicates that adding selectin interactions for existing concentration of activated integrin can lead to firm adhesion (Fig. 3 in Bhatia et al., 2003
). Also, progressive addition of a firm adhesion ligand can lead to the progressive slowing of rolling, with increasing fraction of time paused as shown experimentally in Fig. 10 here (Figs. 4 and 5 in Bhatia et al., 2003
). Furthermore, subsequent theoretical results show that a constant rolling velocity may be achieved through a combination of different integrin and selectin densities, as shown in Fig. 9 here (our unpublished results). Thus the basic principles elucidated by experiment were anticipated by theory, and the results of theory and experiment correspond well.
The question is, to what extent does our cell-free system, in which we explore the effect of P-selectin/ligand interactions on the firm adhesion mediated by ICAM-1 interacting with an antibody, in lieu of activated integrin or I-domain, illustrate principles that apply to leukocytes? We trust readers will recognize that reconstitution of an active integrin in a well-designed orientation, density, and activation state is not trivial given current technology, and a comprehensive biophysical study would not be easily achieved given the likely struggles such a molecule would engender. We do not claim that our system is a mimetic of a leukocyte. Rather, we believe our results suggest mechanisms that leukocytes may use in securing firm binding.
However, we did measure the kinetics of binding of aICAM-1, to compare to the kinetics of activated ß2-integrin binding to ICAM-1. The kinetics of the antibody to ICAM-1 used in our system is similar to that of activated LFA-1. The measured on-rate (kon) for anti-ICAM-1 mAb, BBIG-I1, of 156,000 M-1s-1 is on the same order of magnitude as that of purified I-domain in the locked open position (107,000 M-1s-1) and that of activated
Lß2 integrin (224,000 M-1s-1) (Shimaoka et al., 2002
). The off-rate of the antibody (1.13 x 10-4 s-1) from ICAM-1 is two orders of magnitude lower than that of LFA-1 (2.98 x 10-2 s-1) in its active state. The surprising close correspondence of the on-rate of the BBIG-I1 antibody with ICAM-1, and much lower off-rate, leads to the following interpretations of the results. First a lower off-rate should mean aICAM-1/ICAM-1 interactions are stronger, and better able to support firm adhesion than activated integrin (Chang et al., 2000
). However, the value of having a lower off-rate than integrin is questionable, since the activated ß2-integrin's off-rate is already two orders of magnitude lower than that of P-selectin/PSGL-1 interactions (Alon et al., 1995
). Therefore, aside from some details in the dynamics of rolling conveyed by the lower off-rate, the ability to secure firm adhesion of the antibody should be similar to that of an activated integrin. Also, the ability of aICAM-1/ICAM-1 interactions to support (stabilize) some extent of rolling is consistent with that seen with the integrin I-domain or purified LFA-1 (Salas et al., 2002
), which have also been shown to support rolling. Thus, the antibody functions like integrinit can support firm adhesion at high densities, yet at lower densities, it stabilizes rolling just like ß2-integrins. Second, the on-rate of the antibody is similar to that of ß2-integrins, and therefore the ability of the antibody to capture beads (i.e., the extent of firm adhesion) should also be similar. Thus, we expect the synergy between selectin and antibody to ultimately be similar to that between selectin and integrin, although we fully recognize and look forward to testing these principles in leukocytes or with beads bearing physiological ligands.
A comment on the use of sLeX as a ligand for P-selectin is warranted. Rodgers and co-workers showed that sLeX is a fully functional P-selectin ligand (Rodgers et al., 2000
). Similarly, Brunk and co-workers showed that sLeX and isomer, sLea, are functional ligands for E-selectin (Brunk and Hammer, 1997
). Also, Somers and co-workers showed that a desulfated form of PSGL-1, which bears sLeX, is functional as a P-selectin ligand and structural studies show that an sLeX residue ligates with P-selectin in the desulfated form (Somers et al., 2000
). Rodgers et al. also showed in a cell-free system that desulfated PSGL-1 bearing sLeX supported rolling in a cell-free system (Rodgers et al., 2000
). Thus, with the goal of creating a two-molecule system to identify the interplay between two molecules on beads, the use of sLeX as a selectin ligand seems reasonable. Using this carbohydrate also allowed for a clean comparison with LeX that would not be possible with PSGL-1.
Given the results of this article, and the possibility that the principle illustrated herein may be at play in the transition of leukocyte rolling to firm adhesion, we suggest the following similarities to the adhesion of leukocytes. For one, the dependency of the firm adhesion of our two-receptor microspheres on the wall shear stress within the flow chamber is similar to what has been previously measured for leukocyte adhesion by Simon and co-workers, where they found that the efficiency of integrin dependent adhesion of leukocytes on stimulated, cultured endothelial cells decreases from a maximum as applied shear increases (Simon et al., 2000
). Furthermore, although it has been shown that ICAMs can facilitate some firm adhesion of leukocytes in the absence of selectin-ligand interactions (Gopalan et al., 1997
; Simon et al., 2000
), our results clearly suggest the role selectin-ligand can have in facilitating firm adhesion mediated by a high affinity ligand to ICAM-1 as highlighted in Fig. 6. Finally, rolling velocity data obtained for sLeX/aICAM-1 microspheres interacting with P-selectin/ICAM-1 surfaces show that ICAM-1/antibody interactions slow rolling as shown in Figs. 9 and 10. This observation is similar to what has previously been reported with ß2-integrin (CD18) deficient mice, where the velocities at which leukocytes roll in these mice were observed to be higher than the wild-type suggesting synergistic roles of selectin and ICAMs in leukocyte rolling adhesion (Kunkel et al., 1996
; Jung et al., 1998
). This observation also suggests that the transition from rolling to firm adhesion is a gradual process, where the initial interaction of intercellular adhesion molecules with their ligands serves to stabilize selectin-mediated adhesion to achieve optimum cell interaction with the endothelium. These interactions then eventually lead to firm arrest followed by cell transmigration. Also, the pause times are suspected of having critical effects on downstream signaling, so the ratio of selectin/ICAMs likely has a major effect on the ability of the leukocyte to see and harvest information from endothelium during rolling adhesion. Thus, the biophysical principles elucidated here may very well be involved in leukocyte adhesion.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
We gratefully acknowledge support from National Institutes of Health grants GM59100 and HL18208.
Submitted on September 3, 2002; accepted for publication June 2, 2003.
| REFERENCES |
|---|
|
|
|---|
Bhatia, S. K., M. R. King, and D. A. Hammer. 2003. The state diagram for cell adhesion mediated by two receptors. Biophys. J. 84:26712690.
Blanks, J. E., T. Moll, R. Eytner, and D. Vestweber. 1998. Stimulation of P-selectin glycoprotein ligand-1 on mouse neutrophils activates beta 2-integrin mediated cell attachment to ICAM-1. Eur. J. Immunol. 28:433443.[Medline]
Brunk, D. K., and D. A. Hammer. 1997. Quantifying rolling adhesion with a cell-free assay: E-selectin and its carbohydrate ligands. Biophys. J. 72:28202833.
Butcher, E. C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 67:10331036.[Medline]
Campbell, J. J., and E. C. Butcher. 2000. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 12:336341.[Medline]
Chang, K. C., D. F. Tees, and D. A. Hammer. 2000. The state diagram for cell adhesion under flow: leukocyte rolling and firm adhesion. Proc. Natl. Acad. Sci. USA. 97:1126211267.
Ebnet, K., and D. Vestweber. 1999. Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines. Histochem. Cell Biol. 112:123.[Medline]
Edwards, B. S., M. S. Curry, H. Tsuji, D. Brown, R. S. Larson, and L. A. Sklar. 2000. Expression of P-selectin at low site density promotes selective attachment of eosinophils over neutrophils. J. Immunol. 165:404410.
Eniola, A. O., S. D. Rodgers, and D. A. Hammer. 2002. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. Biomaterials. 23:21672177.[Medline]
Evangelista, V., S. Manarini, R. Sideri, S. Rotondo, N. Martelli, A. Piccoli, L. Totani, P. Piccardoni, D. Vestweber, G. de Gaetano, and C. Cerletti. 1999. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood. 93:876885.
Gopalan, P. K., C. W. Smith, H. Lu, E. L. Berg, L. V. McIntire, and S. I. Simon. 1997. Neutrophil CD18-dependent arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow can be activated through L-selectin. J. Immunol. 158:367375.[Abstract]
Greenberg, A. W., D. K. Brunk, and D. A. Hammer. 2000. Cell-free rolling mediated by L-selectin and sialyl Lewis(x) reveals the shear threshold effect. Biophys. J. 79:23912402.
Jung, U., K. E. Norman, K. Scharffetter-Kochanek, A. L. Beaudet, and K. Ley. 1998. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J. Clin. Invest. 102:15261533.[Medline]
Kunkel, E. J., U. Jung, D. C. Bullard, K. E. Norman, B. A. Wolitzky, D. Vestweber, A. L. Beaudet, and K. Ley. 1996. Absence of trauma-induced leukocyte rolling in mice deficient in both P-selectin and intercellular adhesion molecule 1. J. Exp. Med. 183:5765.
Labadia, M. E., D. D. Jeanfavre, G. O. Caviness, and M. M. Morelock. 1998. Molecular regulation of the interaction between leukocyte function-associated antigen-1 and soluble ICAM-1 by divalent metal cations. J. Immunol. 161:836842.
Lawrence, M. B., and T. A. Springer. 1991. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 65:859873.[Medline]
Munn, L. L., R. J. Melder, and R. K. Jain. 1994. Analysis of cell flux in the parallel plate flow chamber: implications for cell capture studies. Biophys. J. 67:889895.
Rodgers, S. D., R. T. Camphausen, and D. A. Hammer. 2000. Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P- selectin. Biophys. J. 79:694706.
Salas, A., M. Shimaoka, S. Chen, C. V. Carman, and T. A. Springer. 2002. Transition from rolling to firm adhesion is regulated by the conformation of the I domain of the integrin LFA-1. J. Biol. Chem. 277:5025550262.
Shao, J. Y., H. P. Ting-Beall, and R. M. Hochmuth. 1998. Static and dynamic lengths of neutrophil microvilli. Proc. Natl. Acad. Sci. USA. 95:67976802.
Shimaoka, M., J. Takagi, and T. A. Springer. 2002. Conformational regulation of integrin structure and function. Annu. Rev. Biophys. Biomol. Struct. 31:485516.[Medline]
Simon, S. I., Y. Hu, D. Vestweber, and C. W. Smith. 2000. Neutrophil tethering on E-selectin activates beta 2 integrin binding to ICAM-1 through a mitogen-activated protein kinase signal transduction pathway. J. Immunol. 164:43484358.
Somers, W. S., J. Tang, G. D. Shaw, and R. T. Camphausen. 2000. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selection bound to sLe(x) and PSGL-1. Cell. 103:467479.[Medline]
Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301314.[Medline]
Thiel, M., C. Zourelidis, J. D. Chambers, U. H. von Andrian, K. E. Arfors, K. Messmer, and K. Peter. 1997. Expression of beta 2-integrins and L-selectin on polymorphonuclear leukocytes in septic patients. Eur. Surg. Res. 29:160175.[Medline]
This article has been cited by other articles:
![]() |
M. A. McAteer, J. E. Schneider, Z. A. Ali, N. Warrick, C. A. Bursill, C. von zur Muhlen, D. R. Greaves, S. Neubauer, K. M. Channon, and R. P. Choudhury Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Smith, H. Aranda-Espinoza, J. B. Haun, and D. A. Hammer Interplay between Shear Stress and Adhesion on Neutrophil Locomotion Biophys. J., January 15, 2007; 92(2): 632 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Eniola, E. F. Krasik, L. A. Smith, G. Song, and D. A. Hammer I-Domain of Lymphocyte Function-Associated Antigen-1 Mediates Rolling of Polystyrene Particles on ICAM-1 under Flow Biophys. J., November 1, 2005; 89(5): 3577 - 3588. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||